Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.
about
Hereditary Predispositions to Myelodysplastic SyndromeTherapy-Related Myeloid NeoplasmsTP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAsMultiplex degenerate primer design for targeted whole genome amplification of many viral genomes.Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.Simulate_PCR for amplicon prediction and annotation from multiplex, degenerate primers and probesIncreased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.Cancer susceptibility genes and their potential implication regarding systemic therapy for early-stage breast cancer.The evolving challenge of therapy-related myeloid neoplasms.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.Therapy-related myeloid neoplasms: when genetics and environment collide.Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.The TP53 Pro72Arg SNP in de novo acute myeloid leukemia.Acute myeloid leukemia with TP53 germ line mutations.Fanconi anemia gene variants in therapy-related myeloid neoplasms.Preexisting TP53 mutation in therapy-related acute myeloid leukemia.Allogeneic Hematopoietic Stem Cell Transplantation In Therapy-Related Myeloid Neoplasms (t-MN) of the Adult: Monocentric Observational Study and Review of the Literature.The TP53 Pro72Arg SNP in de novo acute myeloid leukaemia - results of two cohort studies involving 215 patients and 3759 controlsBRCA2-associated therapy-related acute myeloid leukemiaWhen to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
P2860
Q26744199-35631C5C-DFE5-4259-9701-0D4ACD7AB673Q26799786-FE68A964-74E5-4CE6-B497-55060F7AAA64Q27853319-5FA8E80B-C932-4114-9D11-BBEE68913403Q28071427-F85406CB-47ED-4CEE-A7CC-3468399EB6B1Q34064148-5E75F647-37AF-4589-9403-9C685E01E35AQ34427193-2C355801-2F89-416F-9E68-94C94691FED4Q34485071-B704DA91-7D87-4C47-8655-D3A31FC0B3DEQ36022862-907804E7-7424-47DC-A19D-4AE40E30E2D6Q36450186-089276A1-42AF-4D83-94EA-2692B4C53D5FQ36450218-8B334869-1029-43D5-AF7B-7F0ACEEE6ADCQ37576054-19CDFA6F-EF7C-4CB1-97A7-1EDE99C9FC9EQ37624593-B832180A-93F6-45AD-88EC-59784286B198Q38202612-CC8D34CC-3F46-4A96-94A7-D84A124B2C99Q38611096-2B72AF0B-F361-4BB6-A157-262C55D406C0Q38979257-5D08FD03-6415-4C1F-9679-F17D011F158AQ39041480-B824C6CF-57D9-4D24-AE50-416139ED71C5Q41184434-A35F4B8D-C38C-47AD-8163-E87D139671DCQ42336323-3A3F0FA6-CF7C-4E75-9A54-265D0D9F4AFFQ42374212-133D0BCC-1A98-4F53-BD00-64D02DC8941FQ42421841-05DFE0A7-9861-4028-BCF8-133F48931040Q43132538-52E0C71F-CB92-4DBA-A002-E412F800F23BQ49233865-FDA5B547-D6F1-45D0-97CF-3A4399E6B02EQ57636601-6CD4D115-45B5-48B9-AE03-D328DD081740Q58050217-D4E38EC6-4315-4ACB-A1B5-52F0C1546931Q59133388-FB2D516F-2991-4979-9CCF-F67579E33717
P2860
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Germline mutations in the DNA ...... apy related myeloid neoplasms.
@en
Germline mutations in the DNA ...... apy related myeloid neoplasms.
@nl
type
label
Germline mutations in the DNA ...... apy related myeloid neoplasms.
@en
Germline mutations in the DNA ...... apy related myeloid neoplasms.
@nl
prefLabel
Germline mutations in the DNA ...... apy related myeloid neoplasms.
@en
Germline mutations in the DNA ...... apy related myeloid neoplasms.
@nl
P2093
P50
P1476
Germline mutations in the DNA ...... rapy related myeloid neoplasms
@en
P2093
Albert Wölfler
Andrea Berghold
Angelika Valentin
Christine Beham-Schmid
Eduard Schulz
Herwig Lackner
Jochen Geigl
Karin Lind
Verena Rupp
Werner Olipitz
P304
P356
10.1136/JMEDGENET-2011-100674
P407
P577
2012-05-31T00:00:00Z